Brief: Evolent Health Q4 Revenue USD 468.719 Million Vs. IBES Estimate USD 468.8 Million
24/02/2026 21:10
Feb 24 (Reuters) - Evolent Health Q4 adjusted EBITDA USD 37.793 million. Q4 adjusted EBITDA margin 8.1% Q4 net income USD -429.131 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows